Genascence

Developing revolutionized life changing gene therapies for prevalent musculoskeletal and joint diseases.

Launch date

2017

Employees

Market cap

Enterprise valuation

Palo Alto California (HQ)

Date	Investors	Amount	Round
Jan 2017*	University of Florida Research Foundation	N/A	Spinout
May 2022*	Pacira Biosciences DeepWork Capital Polymerase Capital University of Florida Research Foundation	$10.5m	Series A
Feb 2023*	California Institute for Regenerative Medicine	$11.6m	Grant
Total Funding		€20.1m

Recent News about Genascence